首页 | 本学科首页   官方微博 | 高级检索  
     

药品上市许可持有人制度下中药饮片委托生产的可行性分析及建议
引用本文:钱利武,金斌. 药品上市许可持有人制度下中药饮片委托生产的可行性分析及建议[J]. 中国药事, 2020, 34(11): 1314-1319
作者姓名:钱利武  金斌
作者单位:安徽省药品审评查验中心,合肥 230051
摘    要:目的:分析在实施药品上市许可持有人制度下开展中药饮片委托生产的可行性。方法:结合我国现有的药品委托生产相关法律法规,对推行中药饮片委托生产的益处和存在的风险进行分析评估。结果与结论:在风险管控的前提下,中药饮片委托生产有助于优化生产资源配置,降低企业生产和管理成本,改进企业现有的质量管理工作,促进饮片行业的健康有序发展。

关 键 词:药品上市许可持有人  中药饮片  委托生产

Feasibility Analysis and Suggestions on the Contract Manufacturing of Chinese Herbal Decoction Pieces Under the System of Marketing Authorization Holder
Qian Liwu,Jin Bin. Feasibility Analysis and Suggestions on the Contract Manufacturing of Chinese Herbal Decoction Pieces Under the System of Marketing Authorization Holder[J]. Chinese Pharmaceutical Affairs, 2020, 34(11): 1314-1319
Authors:Qian Liwu  Jin Bin
Affiliation:Anhui Center for Drug Evaluation & Inspection, Hefei 230051 , China
Abstract:Objective: To analyze the feasibility of contract manufacturing of Chinese herbal decoction pieces under the system of marketing authorization holder. Methods: Based on the existing laws and regulations related to contract manufacturing in China, the advantages and risks of implementing contract manufacturing of Chinese herbal decoction pieces were analyzed and evaluated. Results and Conclusion: Under the premise of risk management and control, the contract manufacturing of Chinese herbal decoction pieces is helpful for enterprises to optimize the allocation of production resources, reduce the production and management costs, improve the quality management, and promote the healthy and orderly development of Chinese herbal decoction pieces industry as well.
Keywords:
点击此处可从《中国药事》浏览原始摘要信息
点击此处可从《中国药事》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号